17/04/2026 (Agence Europe) – In the second quarter of 2026, the European Medicines Agency (EMA) will launch a pilot programme to support breakthrough medical devices andin vitro diagnostics, announced the European Commission on Wednesday 15 April. This scheme aims to accelerate patient access to highly innovative technologies, while maintaining the EU’s high standards of safety and performance. The manufacturers selected will benefit from enhanced regulatory support and priority...